|
| ||||||||||||||||||||||||||||||||||||||||||||||
Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn
PROVISIONAL COMMITTEE ON QUALITY IMPROVEMENT and SUBCOMMITTEE ON HYPERBILIRUBINEMIA
Each year approximately 60% of the 4 million newborns in the United States become clinically jaundiced. Many receive various forms of evaluation and treatment. Few issues in neonatal medicine have generated such long-standing controversy as the possible adverse consequences of neonatal jaundice and when to begin treatment. Questions regarding potentially detrimental neurologic effects from elevated serum bilirubin levels prompt continuing concern and debate, particularly with regard to the management of the otherwise healthy term newborn without risk factors for hemolysis. Although most data are based on infants with birth weights
2500 g, "term" is hereafter defined as 37 completed weeks of gestation.
Under certain circumstances, bilirubin may be toxic to the central nervous system and may cause neurologic impairment even in healthy term newborns. Most studies, however, have failed to substantiate significant associations between a specific level of total serum bilirubin (TSB) during nonhemolytic hyperbilirubinemia in term newborns and subsequent IQ or serious neurologic abnormality (including hearing impairment). Other studies have detected subtle differences in outcomes associated with TSB levels, particularly when used in conjunction with albumin binding tests and/or duration of exposure. In almost all published studies, the TSB concentration has been used as a predictor variable for outcome determinations.
Factors influencing bilirubin toxicity to the brain cells of newborn infants are complex and incompletely understood; they include those that affect the serum albumin concentration and those that affect the binding of bilirubin to albumin, the penetration of bilirubin into the brain, and the vulnerability of brain cells to the toxic effects of bilirubin.
The following policy statement is a revision:
- Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
- Subcommittee on Hyperbilirubinemia
Pediatrics 2004 114: 297-316.[Abstract] [Full Text] [PDF]
This article has been cited by other articles:
![]() |
D. De Luca, G. L. Jackson, A. Tridente, V. P. Carnielli, and W. D. Engle Transcutaneous Bilirubin Nomograms: A Systematic Review of Population Differences and Analysis of Bilirubin Kinetics Arch Pediatr Adolesc Med, November 1, 2009; 163(11): 1054 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Manning Neonatal jaundice: in the eye of the beholder? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2009; 94(5): F314 - F316. [Full Text] [PDF] |
||||
![]() |
J M Rennie, A Sehgal, A De, G S Kendall, and T J Cole Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2009; 94(5): F323 - F327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuzniewicz and T. B. Newman Interaction of Hemolysis and Hyperbilirubinemia on Neurodevelopmental Outcomes in the Collaborative Perinatal Project Pediatrics, March 1, 2009; 123(3): 1045 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Burke, J. M. Robbins, T. M. Bird, C. A. Hobbs, C. Nesmith, and J. M. Tilford Trends in Hospitalizations for Neonatal Jaundice and Kernicterus in the United States, 1988-2005 Pediatrics, February 1, 2009; 123(2): 524 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B Shortland, M. Hussey, and A. Dey Chowdhury Understanding neonatal jaundice: UK practice and international profile Perspectives in Public Health, July 1, 2008; 128(4): 202 - 206. [Abstract] [PDF] |
||||
![]() |
K. A. Jangaard, D. B. Fell, L. Dodds, and A. C. Allen Outcomes in a Population of Healthy Term and Near-Term Infants With Serum Bilirubin Levels of >=325 {micro}mol/L (>=19 mg/dL) Who Were Born in Nova Scotia, Canada, Between 1994 and 2000 Pediatrics, July 1, 2008; 122(1): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O. Ipek and A. Bozaykut Clinically Significant Neonatal Hyperbilirubinemia: An Analysis of 646 Cases in Istanbul J Trop Pediatr, June 1, 2008; 54(3): 211 - 213. [Full Text] [PDF] |
||||
![]() |
A. E. Burgos, S. K. Schmitt, D. K. Stevenson, and C. S. Phibbs Readmission for Neonatal Jaundice in California, 1991-2000: Trends and Implications Pediatrics, April 1, 2008; 121(4): e864 - e869. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Bender, W. J. Cashore, and W. Oh Ontogeny of Bilirubin-Binding Capacity and the Effect of Clinical Status in Premature Infants Born at Less Than 1300 Grams Pediatrics, November 1, 2007; 120(5): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ives Preventing kernicterus: a wake-up call Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F330 - F331. [Full Text] [PDF] |
||||
![]() |
L. A. Steiner, M. J. Bizzarro, R. A. Ehrenkranz, and P. G. Gallagher A Decline in the Frequency of Neonatal Exchange Transfusions and Its Effect on Exchange-Related Morbidity and Mortality Pediatrics, July 1, 2007; 120(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Paul, E. B. Lehman, C. S. Hollenbeak, and M. J. Maisels Preventable Newborn Readmissions Since Passage of the Newborns' and Mothers' Health Protection Act Pediatrics, December 1, 2006; 118(6): 2349 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Eggert, S. E. Wiedmeier, J. Wilson, and R. D. Christensen Effect of Predischarge Bilirubin Screening on Subsequent Hyperbilirubinemia: In Reply Pediatrics, October 1, 2006; 118(4): 1796a - 1797. [Full Text] [PDF] |
||||
![]() |
M. Sgro, D. Campbell, and V. Shah Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Can. Med. Assoc. J., September 12, 2006; 175(6): 587 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and T. B. Newman Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border. Can. Med. Assoc. J., September 12, 2006; 175(6): 599 - 599. [Full Text] [PDF] |
||||
![]() |
A. Datar and N. Sood Impact of Postpartum Hospital-Stay Legislation on Newborn Length of Stay, Readmission, and Mortality in California Pediatrics, July 1, 2006; 118(1): 63 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Erdeve, M Kaplan, and C Hammerman Rebound bilirubin: on what should the decision to recommence phototherapy be based? * Authors' reply Arch. Dis. Child., July 1, 2006; 91(7): 623 - 623. [Full Text] [PDF] |
||||
![]() |
W.-X. Chen, V. C. N. Wong, and K.-Y. Wong Neurodevelopmental Outcome of Severe Neonatal Hemolytic Hyperbilirubinemia J Child Neurol, June 1, 2006; 21(6): 474 - 479. [Abstract] [PDF] |
||||
![]() |
L. D. Eggert, S. E. Wiedmeier, J. Wilson, and R. D. Christensen The Effect of Instituting a Prehospital-Discharge Newborn Bilirubin Screening Program in an 18-Hospital Health System Pediatrics, May 1, 2006; 117(5): e855 - e862. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tiker, H. Gulcan, H. Kilicdag, A. Tarcan, and B. Gurakan Extreme Hyperbilirubinemia in Newborn Infants Clinical Pediatrics, April 1, 2006; 45(3): 257 - 261. [Abstract] [PDF] |
||||
![]() |
V. Wong, W.-X. Chen, and K.-Y. Wong Short- and Long-Term Outcome of Severe Neonatal Nonhemolytic Hyperbilirubinemia J Child Neurol, April 1, 2006; 21(4): 309 - 315. [Abstract] [PDF] |
||||
![]() |
R. P. Wennberg, C. E. Ahlfors, V. K. Bhutani, L. H. Johnson, and S. M. Shapiro Toward Understanding Kernicterus: A Challenge to Improve the Management of Jaundiced Newborns Pediatrics, February 1, 2006; 117(2): 474 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kaplan, E Kaplan, C Hammerman, N Algur, R Bromiker, M S Schimmel, and A I Eidelman Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia Arch. Dis. Child., January 1, 2006; 91(1): 31 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kaplan and C Hammerman American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F448 - F449. [Full Text] [PDF] |
||||
![]() |
D Manning American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F450 - F451. [Full Text] [PDF] |
||||
![]() |
M. L. Moritz, M. D. Manole, D. L. Bogen, and J. C. Ayus Breastfeeding-Associated Hypernatremia: Are We Missing the Diagnosis? Pediatrics, September 1, 2005; 116(3): e343 - e347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Watchko Vigintiphobia Revisited Pediatrics, June 1, 2005; 115(6): 1747 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Alkalay and C. F. Simmons Hyperbilirubinemia Guidelines in Newborn Infants Pediatrics, March 1, 2005; 115(3): 824 - 825. [Full Text] [PDF] |
||||
![]() |
T. B. Newman, P. Liljestrand, and G. J. Escobar Combining Clinical Risk Factors With Serum Bilirubin Levels to Predict Hyperbilirubinemia in Newborns Arch Pediatr Adolesc Med, February 1, 2005; 159(2): 113 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Paul, T. A. Phillips, M. D. Widome, and C. S. Hollenbeak Cost-Effectiveness of Postnatal Home Nursing Visits for Prevention of Hospital Care for Jaundice and Dehydration Pediatrics, October 1, 2004; 114(4): 1015 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Worsley Hyperbilirubinemia Guidelines and Unintended Harms Pediatrics, October 1, 2004; 114(4): 1134 - 1135. [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and on behalf of the Subcommittee on Hyperbilirubinemi Hyperbilirubinemia Guidelines and Unintended Harms: In Reply Pediatrics, October 1, 2004; 114(4): 1135 - 1137. [Full Text] [PDF] |
||||
![]() |
M. J. Maisels Conflict of Interest and Purpose in Bilirubin Screening: In Reply Pediatrics, October 1, 2004; 114(4): 1133 - 1134. [Full Text] [PDF] |
||||
![]() |
R. H. Palmer, S. Ezhuthachan, C. Newman, M. J. Maisels, and M. A. Testa Management of Hyperbilirubinemia in Newborns: Measuring Performance Using a Benchmarking Model Pediatrics, September 1, 2004; 114(3): 902 - 902. [Full Text] [PDF] |
||||
![]() |
R. H. Palmer, S. Ezhuthachan, C. Newman, M. J. Maisels, and M. A. Testa Hyperbilirubinemia Benchmarking Pediatrics, September 1, 2004; 114(3): 902 - 904. [Full Text] [PDF] |
||||
![]() |
C. Lannon and A. R. Stark Closing the Gap Between Guidelines and Practice: Ensuring Safe and Healthy Beginnings Pediatrics, August 1, 2004; 114(2): 494 - 496. [Full Text] [PDF] |
||||
![]() |
M. Kaplan, M. Herschel, C. Hammerman, J. D. Hoyer, and D. K. Stevenson Hyperbilirubinemia Among African American, Glucose-6-Phosphate Dehydrogenase-Deficient Neonates Pediatrics, August 1, 2004; 114(2): e213 - e219. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Blackmon, A. A. Fanaroff, and T. N. K. Raju Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: National Institute of Child Health and Human Development Conference Executive Summary Pediatrics, July 1, 2004; 114(1): 229 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
Subcommittee on Hyperbilirubinemia Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation Pediatrics, July 1, 2004; 114(1): 297 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mehl Intervention Recommendations for Neonatal Hyperbilirubinemia Pediatrics, July 1, 2004; 114(1): 322 - 323. [Full Text] [PDF] |
||||
![]() |
T. B. Newman, P. J. Liljestrand, and G. J. Escobar Hyperbilirubinemia Benchmarking Pediatrics, July 1, 2004; 114(1): 323 - 323. [Full Text] [PDF] |
||||
![]() |
Committee on Fetus and Newborn Hospital Stay for Healthy Term Newborns Pediatrics, May 1, 2004; 113(5): 1434 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Sarici, M. A. Serdar, A. Korkmaz, G. Erdem, O. Oran, G. Tekinalp, M. Yurdakok, and S. Yigit Incidence, Course, and Prediction of Hyperbilirubinemia in Near-Term and Term Newborns Pediatrics, April 1, 2004; 113(4): 775 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Bhutani and L. H. Johnson Urgent Clinical Need for Accurate and Precise Bilirubin Measurements in the United States to Prevent Kernicterus Clin. Chem., March 1, 2004; 50(3): 477 - 480. [Full Text] [PDF] |
||||
![]() |
M. Kaplan, C. Hammerman, T. B. Newman, P. Liljestrand, and G. J. Escobar Infants With Bilirubin Levels of 30 mg/dL or More Pediatrics, February 1, 2004; 113(2): 429 - 430. [Full Text] [PDF] |
||||
![]() |
S. F. Lo, B. T. Doumas, and E. R. Ashwood Performance of Bilirubin Determinations in US Laboratories--Revisited Clin. Chem., January 1, 2004; 50(1): 190 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B Newman The power of stories over statistics BMJ, December 20, 2003; 327(7429): 1424 - 1427. [Full Text] [PDF] |
||||
![]() |
S.-C. Chou, R. H. Palmer, S. Ezhuthachan, C. Newman, B. Pradell-Boyd, M. J. Maisels, and M. A. Testa Management of Hyperbilirubinemia in Newborns: Measuring Performance by Using a Benchmarking Model Pediatrics, December 1, 2003; 112(6): 1264 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Javier, A. Krauss, and M. Nesin Corrected End-Tidal Carbon Monoxide Closely Correlates With the Corrected Reticulocyte Count in Coombs' Test-Positive Term Neonates Pediatrics, December 1, 2003; 112(6): 1333 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Palmer, M. Clanton, S. Ezhuthachan, C. Newman, J. Maisels, P. Plsek, and S. Salem-Schatz Applying the "10 Simple Rules" of the Institute of Medicine to Management of Hyperbilirubinemia in Newborns Pediatrics, December 1, 2003; 112(6): 1388 - 1393. [Full Text] [PDF] |
||||
![]() |
L. Davidson and E. H. Thilo How to Make Kernicterus a "Never Event" NeoReviews, November 1, 2003; 4(11): e308 - 314. [Full Text] [PDF] |
||||
![]() |
M. Pezzati, S. Rossi, M. Tronchin, C. Dani, L. Filippi, and F. F. Rubaltelli Umbilical Cord Care in Premature Infants: The Effect of Two Different Cord-Care Regimens (Salicylic Sugar Powder vs Chlorhexidine) on Cord Separation Time and Other Outcomes Pediatrics, October 1, 2003; 112(4): e275 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Beck, N Kau, and H Schlebusch Transcutaneous bilirubin measurement in newborn infants: evaluation of a new spectrophotometric method Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2003; 88(4): F350 - F351. [Full Text] [PDF] |
||||
![]() |
T. B. Newman, P. Liljestrand, and G. J. Escobar Infants With Bilirubin Levels of 30 mg/dL or More in a Large Managed Care Organization Pediatrics, June 1, 2003; 111(6): 1303 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Ahlfors and O. Herbsman Unbound Bilirubin in a Term Newborn With Kernicterus Pediatrics, May 1, 2003; 111(5): 1110 - 1112. [Full Text] [PDF] |
||||
![]() |
L. R. Atkinson, G. J. Escobar, J. I. Takayama, and T. B. Newman Phototherapy Use in Jaundiced Newborns in a Large Managed Care Organization: Do Clinicians Adhere to the Guideline? Pediatrics, May 1, 2003; 111(5): e555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, J. Zhang, S. S. Chua, M. Qatanani, Y. Han, R. Granata, and D. D. Moore Induction of bilirubin clearance by the constitutive androstane receptor (CAR) PNAS, April 1, 2003; 100(7): 4156 - 4161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaplan, C. Hammerman, and M. J. Maisels Bilirubin Genetics for the Nongeneticist: Hereditary Defects of Neonatal Bilirubin Conjugation Pediatrics, April 1, 2003; 111(4): 886 - 893. [Full Text] [PDF] |
||||
![]() |
V. K. Bhutani, L. H. Johnson, G. Gourley, W. D. Engle, and G. L. Jackson Measuring Bilirubin Through the Skin? Pediatrics, April 1, 2003; 111(4): 919 - 920. [Full Text] [PDF] |
||||
![]() |
A. Riskin, M. Abend-Weinger, and D. Bader How Accurate are Neonatologists in Identifying Clinical Jaundice in Newborns? Clinical Pediatrics, March 1, 2003; 42(2): 153 - 158. [Abstract] [PDF] |
||||
![]() |
A. K. Brown Kernicterus: Past, Present, and Future NeoReviews, February 1, 2003; 4(2): e33 - 40. [Full Text] [PDF] |
||||
![]() |
T. B. Newman, P. Liljestrand, and G. J. Escobar Jaundice Noted in the First 24 Hours After Birth in a Managed Care Organization Arch Pediatr Adolesc Med, December 1, 2002; 156(12): 1244 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paludetto, G. Mansi, F. Raimondi, A. Romano, V. Crivaro, M. Bussi, and G. D'Ambrosio Moderate Hyperbilirubinemia Induces a Transient Alteration of Neonatal Behavior Pediatrics, October 1, 2002; 110(4): e50 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Wong, P J E van Dijk, and I A Laing A comparison of transcutaneous bilirubinometers: SpectRx BiliCheck versus Minolta AirShields Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2002; 87(2): F137 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and E. Kring Rebound in Serum Bilirubin Level Following Intensive Phototherapy Arch Pediatr Adolesc Med, July 1, 2002; 156(7): 669 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herschel, T. Karrison, M. Wen, L. Caldarelli, and B. Baron Isoimmunization Is Unlikely to Be the Cause of Hemolysis in ABO-Incompatible but Direct Antiglobulin Test-Negative Neonates Pediatrics, July 1, 2002; 110(1): 127 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Garcia and A. L. Nager Jaundice as an Early Diagnostic Sign of Urinary Tract Infection in Infancy Pediatrics, May 1, 2002; 109(5): 846 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Hannon, S. K. Willis, and S. C. Scrimshaw Persistence of Maternal Concerns Surrounding Neonatal Jaundice: An Exploratory Study Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1357 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rolinski, H. Kuster, B. Ugele, R. Gruber, and K. Horn Total Bilirubin Measurement by Photometry on a Blood Gas Analyzer: Potential for Use in Neonatal Testing at the Point of Care, Clin. Chem., October 1, 2001; 47(10): 1845 - 1847. [Full Text] [PDF] |
||||
![]() |
AAP Subcommittee on Neonatal Hyperbilirubinemia Neonatal Jaundice and Kernicterus Pediatrics, September 1, 2001; 108(3): 763 - 765. [Abstract] [Full Text] |
||||
![]() |
R. A. Polin Kernicterus in Full-Term Infants Is Still a Problem in the US AAP Grand Rounds, August 1, 2001; 6(2): 17 - 18. [Full Text] [PDF] |
||||
![]() |
Kernicterus in Full-Term Infants--United States, 1994-1998 JAMA, July 18, 2001; 286(3): 299 - 300. [Full Text] [PDF] |
||||
![]() |
F. F. Rubaltelli, G. R. Gourley, N. Loskamp, N. Modi, M. Roth-Kleiner, A. Sender, and P. Vert Transcutaneous Bilirubin Measurement: A Multicenter Evaluation of a New Device Pediatrics, June 1, 2001; 107(6): 1264 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O'Keefe Increased vigilance needed to prevent kernicterus in newborns AAP News, May 1, 2001; 18(5): 231 - 231. [Full Text] [PDF] |
||||
![]() |
D. J. Madlon-Kay Home Health Nurse Clinical Assessment of Neonatal Jaundice: Comparison of 3 Methods Arch Pediatr Adolesc Med, May 1, 2001; 155(5): 583 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Harris, J. C. Bernbaum, J. R. Polin, R. Zimmerman, and R. A. Polin Developmental Follow-Up of Breastfed Term and Near-Term Infants With Marked Hyperbilirubinemia Pediatrics, May 1, 2001; 107(5): 1075 - 1080. [Abstract] [Full Text] |
||||
![]() |
T. B. Newman, B. Xiong, V. M. Gonzales, and G. J. Escobar Prediction and Prevention of Extreme Neonatal Hyperbilirubinemia in a Mature Health Maintenance Organization Arch Pediatr Adolesc Med, November 1, 2000; 154(11): 1140 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Bhutani, G. R. Gourley, S. Adler, B. Kreamer, C. Dalin, and L. H. Johnson Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia Pediatrics, August 1, 2000; 106(2): 17e - 17. [Abstract] [Full Text] |
||||
![]() |
V. A. Moyer, C. Ahn, and S. Sneed Accuracy of Clinical Judgment in Neonatal Jaundice Arch Pediatr Adolesc Med, April 1, 2000; 154(4): 391 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Gourley Breastfeeding, Diet, and Neonatal Hyperbilirubinemia NeoReviews, February 1, 2000; 1(2): e25 - 31. [Full Text] |
||||
![]() |
T. B. Newman and M. J. Maisels Less Aggressive Treatment of Neonatal Jaundice and Reports of Kernicterus: Lessons About Practice Guidelines Pediatrics, January 1, 2000; 105(1): 242 - 245. [Abstract] [Full Text] |
||||
![]() |
T. B. Newman, G. J. Escobar, V. M. Gonzales, M. A. Armstrong, M. N. Gardner, and B. F. Folck Frequency of Neonatal Bilirubin Testing and Hyperbilirubinemia in a Large Health Maintenance Organization Pediatrics, November 1, 1999; 104(5): 1198 - 1203. [Abstract] [Full Text] |
||||
![]() |
G. S. Hertz, G. R. Gourley, B. Kreamer, and M. Kosorok Nutrition and Jaundice: Hold the Bottle, Keep the Breast Arch Pediatr Adolesc Med, September 1, 1999; 153(9): 1002 - 1003. [Full Text] [PDF] |
||||
![]() |
R. N. Shiffman, C. A. Brandt, Y. Liaw, and G. J. Corb A Design Model for Computer-based Guideline Implementation Based on Information Management Services J. Am. Med. Inform. Assoc., March 1, 1999; 6(2): 99 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and T. B. Newman Predicting Hyperbilirubinemia in Newborns: The Importance of Timing Pediatrics, February 1, 1999; 103(2): 493 - 494. [Full Text] |
||||
![]() |
J. C. Martinez, H. O. Garcia, L. E. Otheguy, G. S. Drummond, and A. Kappas Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin Pediatrics, January 1, 1999; 103(1): 1 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Bhutani, L. Johnson, and E. M. Sivieri Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns Pediatrics, January 1, 1999; 103(1): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Wiley, N. Lai, C. Hill, and G. Burke Nursery Practices and Detection of Jaundice After Newborn Discharge Arch Pediatr Adolesc Med, October 1, 1998; 152(10): 972 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cadwell Bilirubin Status as an Outcome Measure in Monitoring Adherence to Baby-Friendly Breastfeeding Policies in Hospitals and Birthing Centers in the United States J Hum Lact, September 1, 1998; 14(3): 187 - 189. [PDF] |
||||
![]() |
T. Valaes, G. S. Drummond, and A. Kappas Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin Pediatrics, May 1, 1998; 101 (5): e1 - e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Christakis and F. P. Rivara Pediatricians' Awareness of and Attitudes About Four Clinical Practice Guidelines Pediatrics, May 1, 1998; 101(5): 825 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Nazarian and W. O. Robertson Personal Reflections on the AAP Practice Parameter on Management of Hyperbilirubinemia in the Healthy Term Newborn Pediatr. Rev., March 1, 1998; 19(3): 75 - 77. [Full Text] [PDF] |
||||
![]() |
L. M. Gartner, C. T. Herrarias, and R. H. Sebring Practice Patterns in Neonatal Hyperbilirubinemia Pediatrics, January 1, 1998; 101(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Halamek, D. K. Stevenson;, and J. M. Perlman Kernicteric Findings at Autopsy in Two Sick Near Term Infants Pediatrics, January 1, 1998; 101 (1): 158 - 158. [Full Text] |
||||
![]() |
A. F. Jerant and T. D. Epperly Early Discharge of Newborns JAMA, December 17, 1997; 278(23): 2066 - 2066. [Abstract] [PDF] |
||||
![]() |
D. J. Madlon-Kay Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer Pediatrics, September 1, 1997; 100(3): e3 - e3. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Stevenson and H. J. Vreman Carbon Monoxide and Bilirubin Production in Neonates Pediatrics, August 1, 1997; 100(2): 252 - 259. [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and E. Kring Early Discharge From the Newborn Nursery---Effect on Scheduling of Follow-up Visits by Pediatricians Pediatrics, July 1, 1997; 100(1): 72 - 74. [Abstract] [Full Text] [PDF] |
||||




















